{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:13:35Z","timestamp":1788556415774,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS117852"],"award-info":[{"award-number":["R21NS117852"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omta.2026.201670","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:17:57Z","timestamp":1768263477000},"page":"201670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advancing AADC deficiency therapy through MR-guided multisite delivery of AAV2-hAADC to dopaminergic and serotonergic pathways in the brainstem"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-473X","authenticated-orcid":false,"given":"Lluis","family":"Samaranch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Neudorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Munjal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meika","family":"Travis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitvir S.","family":"Taunque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaya E.","family":"Ceyhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhila","family":"Dandamudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Karkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Nimmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bringas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad S.","family":"Akhter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Youngblood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Mattox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Mark","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Forsayeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell R.","family":"Lonser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystof S.","family":"Bankiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201670_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF01799380","article-title":"Aromatic amino acid decarboxylase deficiency in twins","volume":"13","author":"Hyland","year":"1990","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.omta.2026.201670_bib2","author":"National Organization for Rare Diseases"},{"key":"10.1016\/j.omta.2026.201670_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejpn.2008.03.008","article-title":"Aromatic L-amino acid decarboxylase deficiency in Taiwan","volume":"13","author":"Lee","year":"2009","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.omta.2026.201670_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10545-009-1076-1","article-title":"Aromatic L-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up","volume":"32","author":"Manegold","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.omta.2026.201670_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymgme.2019.03.009","article-title":"Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook","volume":"127","author":"Himmelreich","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omta.2026.201670_bib6","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/jimd.12247","article-title":"AADC deficiency from infancy to adulthood: Symptoms and developmental outcome in an international cohort of 63 patients","volume":"43","author":"Pearson","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.omta.2026.201670_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.1969.00480160015001","article-title":"Treatment of Parkinsonism With Levodopa","volume":"21","author":"Yahr","year":"1969","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.omta.2026.201670_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13023-016-0522-z","article-title":"Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency","volume":"12","author":"Wassenberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omta.2026.201670_bib9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/mds.27993","article-title":"Aromatic L-Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson\u2019s Disease","volume":"35","author":"Nutt","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.omta.2026.201670_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1212\/WNL.0b013e3181e620ae","article-title":"Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency","volume":"75","author":"Brun","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.omta.2026.201670_bib11","series-title":"Basic Neurochemistry: Molecular, Cellular and Medical Aspects","article-title":"Biosynthesis of Catecholamines","author":"Kuhar","year":"1999"},{"key":"10.1016\/j.omta.2026.201670_bib12","series-title":"Basic Neurochemistry: Molecular, Cellular and Medical Aspects","article-title":"Storage and Release of Catecholamines","author":"Kuhar","year":"1999"},{"key":"10.1016\/j.omta.2026.201670_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1284339","article-title":"Case report: Childhood epilepsy and borderline intellectual functioning hiding an AADC deficiency disorder associated with compound heterozygous DDC gene pathogenic variants","volume":"14","author":"Cursio","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.omta.2026.201670_bib14","doi-asserted-by":"crossref","first-page":"134ra61","DOI":"10.1126\/scitranslmed.3003640","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency","volume":"4","author":"Hwu","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2026.201670_bib15","first-page":"265","article-title":"Efficacy and safety of AAV2 gene therapy in children with aromatic L-amino acid decarboxylase deficiency: an open-label, phase 1\/2 trial. Lancet Child Adolesc","volume":"1","author":"Chien","year":"2017","journal-title":"Health"},{"key":"10.1016\/j.omta.2026.201670_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1006\/exnr.2000.7408","article-title":"Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach","volume":"164","author":"Bankiewicz","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.omta.2026.201670_bib17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ymthe.2006.05.005","article-title":"Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC","volume":"14","author":"Bankiewicz","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201670_bib18","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1073\/pnas.0810682106","article-title":"Efficient gene therapy-based method for the delivery of therapeutics to primate cortex","volume":"106","author":"Kells","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.omta.2026.201670_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1089\/hum.2011.162","article-title":"Safety and Tolerability of Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery of AAV2-hAADC with a Novel Delivery Platform in Nonhuman Primate Striatum","volume":"23","author":"San Sebastian","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201670_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.nbd.2011.10.004","article-title":"Glial-derived neurotrophic factor gene transfer for Parkinson\u2019s disease: Anterograde distribution of AAV2 vectors in the primate brain","volume":"48","author":"Kells","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omta.2026.201670_bib21","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1074\/jbc.M109.054510","article-title":"A biochemical and functional protein complex involving dopamine synthesis and transport into synaptic vesicles","volume":"285","author":"Cartier","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2026.201670_bib22","article-title":"Safety and tolerability of MRI-guided infusion of AAV2-hAADC into the mid-brain of nonhuman primate","volume":"3","author":"San Sebastian","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201670_bib23","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1038\/s41467-021-24524-8","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons","volume":"12","author":"Pearson","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201670_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3171\/2018.10.JNS182169","article-title":"Development of a novel frameless skull-mounted ball-joint guide array for use in image-guided neurosurgery","volume":"132","author":"Sudhakar","year":"2020","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.omta.2026.201670_bib25","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fnins.2020.00579","article-title":"Neurofilament-Light Chain as Biomarker of Neurodegenerative and Rare Diseases With High Translational Value","volume":"14","author":"Loeffler","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.omta.2026.201670_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jchemneu.2009.06.010","article-title":"Aromatic L-amino acid decarboxylase-immunoreactive structures in human midbrain, pons, and medulla","volume":"38","author":"Kitahama","year":"2009","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.omta.2026.201670_bib27","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/WNL.0b013e3181c29356","article-title":"Safety and tolerability of putaminal AADC gene therapy for Parkinson disease","volume":"73","author":"Christine","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.omta.2026.201670_bib28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3171\/jns.2002.97.4.0905","article-title":"Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion","volume":"97","author":"Lonser","year":"2002","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.omta.2026.201670_bib29","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/neuonc\/noy070","article-title":"Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma","volume":"20","author":"Gupta","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omta.2026.201670_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3171\/2020.6.PEDS20280","article-title":"Repeat convection-enhanced delivery for diffuse intrinsic pontine glioma","volume":"26","author":"Bander","year":"2020","journal-title":"J. Neurosurg. Pediatr."},{"key":"10.1016\/j.omta.2026.201670_bib31","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1212\/WNL.0000000000012952","article-title":"Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial","volume":"98","author":"Christine","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.omta.2026.201670_bib32","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/mds.30193","article-title":"Intraputaminal Delivery of Adeno-Associated Virus Serotype 2-Glial Cell Line-Derived Neurotrophic Factor in Mild or Moderate Parkinson\u2019s Disease","volume":"40","author":"Van Laar","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.omta.2026.201670_bib33","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/s41593-025-01978-3","article-title":"A dynamic and multimodal framework to define microglial states","volume":"28","author":"Sankowski","year":"2025","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omta.2026.201670_bib34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ymthe.2003.12.005","article-title":"Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAV","volume":"9","author":"Sanftner","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201670_bib35","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2174\/1871527322666230609141519","article-title":"Oxidative Stress and Dopaminergic Metabolism: A Major PD Pathogenic Mechanism and Basis of Potential Antioxidant Therapies","volume":"23","author":"Rasool","year":"2024","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.omta.2026.201670_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1478-811X-11-34","article-title":"Complexity of dopamine metabolism","volume":"11","author":"Meiser","year":"2013","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.omta.2026.201670_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-4165(98)00062-2","article-title":"Hydroxyl radical formation via iron-mediated Fenton chemistry is inhibited by methylated catechols","volume":"1425","author":"Nappi","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omta.2026.201670_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.826193","article-title":"Evidence That Substantia Nigra Pars Compacta Dopaminergic Neurons Are Selectively Vulnerable to Oxidative Stress Because They Are Highly Metabolically Active","volume":"16","author":"Ni","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.omta.2026.201670_bib39","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3390\/ijms22063027","article-title":"Microglia Diversity in Healthy and Diseased Brain: Insights from Single-Cell Omics","volume":"22","author":"Ochocka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omta.2026.201670_bib40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2174\/156652310793180715","article-title":"Manufacturing and regulatory strategies for clinical AAV2-hRPE65","volume":"10","author":"Wright","year":"2010","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omta.2026.201670_bib41","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/mt.2008.111","article-title":"Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain","volume":"16","author":"Cunningham","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201670_bib42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/gt.2015.87","article-title":"Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response","volume":"23","author":"Samaranch","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201670_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1091581820966315","article-title":"Safety Assessment of AAV2-hGDNF Administered Via Intracerebral Injection in Rats for Treatment of Parkinson\u2019s Disease","volume":"40","author":"Terse","year":"2021","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.omta.2026.201670_bib44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nurt.2007.10.064","article-title":"Image-guided convection-enhanced delivery platform in the treatment of neurological diseases","volume":"5","author":"Fiandaca","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.omta.2026.201670_bib45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72929","article-title":"Lead-OR: A multimodal platform for deep brain stimulation surgery","volume":"11","author":"Oxenford","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.omta.2026.201670_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2023.119862","article-title":"Lead-DBS v3.0: Mapping deep brain stimulation effects to local anatomy and global networks","volume":"268","author":"Neudorfer","year":"2023","journal-title":"Neuroimage"},{"key":"10.1016\/j.omta.2026.201670_bib47","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.1038\/s41598-021-87564-6","article-title":"The ANTsX ecosystem for quantitative biological and medical imaging","volume":"11","author":"Tustison","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201670_bib48","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.neuroimage.2010.09.025","article-title":"A reproducible evaluation of ANTs similarity metric performance in brain image registration","volume":"54","author":"Avants","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.omta.2026.201670_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.118759","article-title":"High-resolution mapping and digital atlas of subcortical regions in the macaque monkey based on matched MAP-MRI and histology","volume":"245","author":"Saleem","year":"2021","journal-title":"Neuroimage"}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:30:38Z","timestamp":1788553838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S3117387X26000054"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201670","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing AADC deficiency therapy through MR-guided multisite delivery of AAV2-hAADC to dopaminergic and serotonergic pathways in the brainstem","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201670"}}